These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11164753)

  • 1. Encephalopathy following Loa loa treatment with albendazole.
    Blum J; Wiestner A; Fuhr P; Hatz C
    Acta Trop; 2001 Jan; 78(1):63-5. PubMed ID: 11164753
    [No Abstract]   [Full Text] [Related]  

  • 2. Encephalopathy in a patient with loiasis treated with albendazole: A case report.
    Volpicelli L; De Angelis M; Morano A; Biliotti E; Franchi C; Gabrielli S; Mattiucci S; Di Bonaventura C; Taliani G
    Parasitol Int; 2020 Apr; 75():102006. PubMed ID: 31676328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial.
    Kamgno J; Nguipdop-Djomo P; Gounoue R; Téjiokem M; Kuesel AC
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004492. PubMed ID: 26967331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where next with Loa loa encephalopathy? Data are badly needed.
    Mackenzie C; Geary T; Prichard R; Boussinesq M
    Trends Parasitol; 2007 Jun; 23(6):237-8. PubMed ID: 17459773
    [No Abstract]   [Full Text] [Related]  

  • 5. Human loiasis in a Cameroonian village: a double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen.
    Tabi TE; Befidi-Mengue R; Nutman TB; Horton J; Folefack A; Pensia E; Fualem R; Fogako J; Gwanmesia P; Quakyi I; Leke R
    Am J Trop Med Hyg; 2004 Aug; 71(2):211-5. PubMed ID: 15306713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia.
    Tsague-Dongmo L; Kamgno J; Pion SD; Moyou-Somo R; Boussinesq M
    Ann Trop Med Parasitol; 2002 Oct; 96(7):707-15. PubMed ID: 12537632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loiasis, a Subconjunctival Manifestation.
    Peñafiel-Freire DM; Herranz-Aguirre M
    J Pediatr; 2017 Sep; 188():300. PubMed ID: 28595769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Loa loa meningoencephalitis secondary to treatment with mebendazol].
    Moliner JV; Valverde AG; Sorolla JM
    Med Clin (Barc); 2011 Feb; 136(5):228-9. PubMed ID: 20434735
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia.
    Kamgno J; Boussinesq M
    Parasite; 2002 Mar; 9(1):59-63. PubMed ID: 11938697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loa loa filariasis, encephalitis and treatment with Notézine: an underestimated complication?].
    Brice D; Etienne SD; Le Thi Huong Du; Wechsler B; Chandenier J; Piette JC; Godeau P
    Ann Med Interne (Paris); 1989; 140(4):319-20. PubMed ID: 2782773
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy.
    Gobbi F; Buonfrate D; Tamarozzi F; Degani M; Angheben A; Bisoffi Z
    Emerg Infect Dis; 2019 Aug; 25(8):1574-1576. PubMed ID: 31310225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
    Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
    Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
    Fobi G; Gardon J; Santiago M; Ngangue D; Gardon-Wendel N; Boussinesq M
    Ophthalmic Epidemiol; 2000 Mar; 7(1):27-39. PubMed ID: 10652169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loa loa-does it deserve to be neglected?
    Metzger WG; Mordmüller B
    Lancet Infect Dis; 2014 Apr; 14(4):353-7. PubMed ID: 24332895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of loiasis in Rome.
    Morrone A; Franco G; Toma L; Tchangmena OB; Marangi M
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):280-3. PubMed ID: 12195573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin for treating post-ivermectin Loa-related serious adverse events?
    Boussinesq M; Kamgno J; Pion SD; Mackenzie CD
    Trends Parasitol; 2010 Jan; 26(1):4-5. PubMed ID: 19879192
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
    Kamgno J; Gardon J; Boussinesq M
    Med Trop (Mars); 2000; 60(3):275-7. PubMed ID: 11258063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Loa loa Microfilaremia with Imatinib - A Case Report.
    O'Connell EM; Nutman TB
    N Engl J Med; 2017 Nov; 377(21):2095-2096. PubMed ID: 29166233
    [No Abstract]   [Full Text] [Related]  

  • 20. [A patient with loiasis following a trip to Central Africa].
    van Kortenhof NM; Jaspers CA; Sanders CJ
    Ned Tijdschr Geneeskd; 2003 Jul; 147(27):1327-9. PubMed ID: 12868163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.